TransCutan develops and markets the next generation access technology solution.
TransCutan was founded in 2001 by a professor at the Academic Hospital in Uppsala. His vision was to develop unique ideas about intracorporeal access systems, so-called transcutaneous ports.
TransCutan's first product, the T-Port©, was tested in patients for the first time in 2003. It is used to deliver medications and nutrition to the gastrointestinal tract. T-Port© was CE-marked in March 2014. Since 2016 we are also distributing some unique medical devices in Sweden.
We are working on further development of our concept to adapt it to other indications. Our first goal is a trancutaneous port for dialysis.